Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Major trial shows breast cancer drug can hit prostate cancer Achilles heel
A drug already licensed for the treatment of breast and ovarian cancers is more effective…
A step toward a better way to make gene therapies to attack cancer and genetic disorders
A UCLA-led US research team today reports that it has developed a new method for…
New type of immune cell discovered in breast ducts
Melbourne breast cancer researchers have discovered a new type of immune cell that helps to…
Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive breast cancer
- Updated APHINITY trial data show addition of pertuzumab to trastuzumab plus chemotherapy continues to yield clinical benefit in patients with operable HER2-positive early breast cancer
- New HER2 antibody-drug conjugate yielded promising clinical responses in breast cancer patients pretreated with T-DM1
- Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer
I had alcohol-related breast cancer. Here’s why I still drink
By Joanna Moorhead – The Guardian. The chief medical officer advises women to think about cancer when having a drink. But…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.